Swedish Radiosurgery Center Advances Prostate Cancer Care With 5-Session CyberKnife Treatment
Updated
Updated · MyNorthwest · Jun 9
Swedish Radiosurgery Center Advances Prostate Cancer Care With 5-Session CyberKnife Treatment
1 articles · Updated · MyNorthwest · Jun 9
Summary
Swedish Radiosurgery Center said its prostate cancer program combines CyberKnife with Uber Nerve Sparing to target tumors while reducing sexual side effects and preserving quality of life.
CyberKnife tracks prostate movement in real time and delivers radiation with sub-millimeter accuracy, allowing clinicians to spare nearby healthy tissue and critical nerve bundles.
The center said the regimen typically takes just 5 sessions, each under an hour, with most patients resuming normal activities quickly and seeing less urinary and bowel disruption.
The push comes during Men’s Health Month as prostate cancer remains the most commonly diagnosed male cancer in the U.S., with 333,830 new cases and more than 36,000 deaths projected for 2026.
Are advanced prostate cancer therapies like CyberKnife and NanoKnife accessible for the average patient?
As treatments improve quality of life, is prostate cancer becoming a manageable chronic disease?
With new treatments emerging globally, how can patients choose the best option for them?
Transforming Prostate Cancer Treatment: Swedish’s CyberKnife S7, AI, and the Future of Radiosurgery
Overview
As of 2026, the CyberKnife S7 System marks a major step forward in precision radiosurgery, especially for prostate cancer. Launched by Accuray and adopted by leading centers like Swedish, this system uses a robotic, non-invasive approach to deliver highly targeted radiation with exceptional accuracy. Its advanced technology expands treatment options for cases that were previously difficult to manage. The CyberKnife S7’s precision is supported by clinical studies and real-world use, such as at Geisinger Wyoming Valley Medical Center, the first to treat patients with this system. This innovation is helping set new standards in cancer care.